JPRN-UMIN000017668
Completed
N/A
A pilot study of definitive chemoradiotherapy using involved-field intensity-modulatd radiation therapy for patients with clinical stage IB-IIIC (non T4) esophageal carcinoma - A pilot study of definitive chemoradiotherapy using involved-field intensity-modulatd radiation therapy for patients with clinical stage IB-IIIC (non T4) esophageal carcinoma
Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University0 sites12 target enrollmentJuly 23, 2015
ConditionsEsophageal neoplasm
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Esophageal neoplasm
- Sponsor
- Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University
- Enrollment
- 12
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Simultaneous or metachronous (within 5 years) double cancers , with the exception of intramucosal tumor curable with local therapy 2\) Active infection requiring systemic therapy 3\) Fever over 38 degrees Celsius 4\) Pregnant or lactating women or women of childbearing potential 5\) Psychosis 6\) Patients requiring systemic steroids medication 7\) Serum HBs antigen positive within 1 year 8\) Poorly controlled diabetes mellitus 9\) Unstable angina within 3 weeks, or with a history of myocardial infarction within 6 months. 10\) Interstitial pneumonia, fibroid lung, or severe emphysema 11\) History of cerebrovascular disorder within 6 months 12\) Connective tissue disease 13\) History of a surgical resection for esophagus
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 1
Phase I Study of definitive chemoradiotherapy with Docetaxel, CDDP and 5-FU for Unresectable or Recurrent Esophageal Canceradvanced or recurrence esophageal carcinomaJPRN-UMIN000003634Department of Surgery, Graduate School of Medicine, Osaka University18
Not Yet Recruiting
Phase 1
Phase I study of definitive chemoradiotherapy with paclitaxel, CDDP and 5-FU (PCF-RT) for clinical stage IA-IIIC esophageal canceresophageal cancerJPRN-UMIN000028589Osaka international cancer institute24
Recruiting
Phase 1
Phase I study of definitive CRT with paclitaxel, CDDP and 5-FU for clinical stage IA-IIIC esophageal cancer.(PCF-RT)Esophageal cancerJPRN-jRCTs051180082Yamamoto Sachiko24
Completed
Phase 1
Phase I trial of definitive chemoradiotherapy with paclitaxel, cisplatin, and 5-FU (PCF-RT) for esophageal canceresophageal cancerJPRN-UMIN000014927Aichi Cancer Center Hospital18
Completed
Phase 2
A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced esophageal carcinoma (KDOG 0501 P2)locally advanced esophageal carcinomaJPRN-UMIN000002029Kitasato University School of Medicine35